DAVELIZOMIB
UNII T3LN9U6BRF

Substance Identification & Data

This profile provides standardized clinical and technical data for Davelizomib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T3LN9U6BRF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2409841-51-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
T3LN9U6BRF
CAS Registry Number
2409841-51-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAVELIZOMIB
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H26BF2N3O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
BMSAGHWUHGTMIV-ULQDDVLXSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
12698
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(NCC(N[C@@H](CC(C)C)B1O[C@@H](CC(O)=O)C(=O)O1)=O)(=O)[C@H]2N(CC2)c3c(F)cc(F)cc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Davelizomib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAVELIZOMIB

Common Names & Synonyms

1,3,2-DIOXABOROLANE-4-ACETIC ACID, 2-((1R)-1-((2-((((2S)-1-(2,4-DIFLUOROPHENYL)-2-AZETIDINYL)CARBONYL)AMINO)ACETYL)AMINO)-3-METHYLBUTYL)-5-OXO-, (4S)-
DAVELIZOMIB [INN]